What is the additional mean IOP reduction associated with Rhopressa?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What is the additional mean IOP reduction associated with Rhopressa?

Explanation:
Rhopressa (netarsudil) works by increasing aqueous humor outflow through the trabecular meshwork and by lowering episcleral venous pressure, giving a modest but real drop in IOP. When added to existing glaucoma therapy, the typical incremental reduction in mean IOP is about a couple of millimeters of mercury. This add-on effect is consistent with its mechanism, providing an extra push on outflow alongside other agents that may work through different pathways. While some patients may see a bit more or a bit less due to individual variability, the average additional fall is in that modest range, which is why this option is considered the best choice for the question.

Rhopressa (netarsudil) works by increasing aqueous humor outflow through the trabecular meshwork and by lowering episcleral venous pressure, giving a modest but real drop in IOP. When added to existing glaucoma therapy, the typical incremental reduction in mean IOP is about a couple of millimeters of mercury. This add-on effect is consistent with its mechanism, providing an extra push on outflow alongside other agents that may work through different pathways. While some patients may see a bit more or a bit less due to individual variability, the average additional fall is in that modest range, which is why this option is considered the best choice for the question.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy